LONGITUDINAL MICROBIOME AND METABOLOME DATA ANALYSIS AND VARIATION IN HOST CLINICAL RESPONSE
MECHANISMS OF HOST-MICROBIOME INTERACTIONS IN MODULATION OF DRUG METABOLISM AND RESPONSE
MICROBIOME AND METABOLOME MACHINE LEARNING MODELS ON DISEASE BIOMARKER DISCOVERY COHORTS
Longitudinal microbiome-metabolome data analysis in clinical research
How We Do It
Who We Are
Bringing together worldwide experts in mass spectrometry and next-generation sequencing, on the cloud, to elucidate how human microbiota communicate with their host and provide valuable insights for clinical research.
Evguenia Kopylova, PhD
Creating advanced analytical algorithms to accelerate the development of microbiome-based therapeutics.
Senior Metabolomics Adviser
Identifying potential therapeutics within complex microbial communities using modern mass spectrometry methods and advanced computational approaches.
Marketing & Analytics Lead
Accelerating the adoption of statistical programming to automate marketing processes and optimize the performance of sales enablement initiatives.
Rayan Chikhi, PhD
Developing big data computation algorithms and optimizing tools for analysis of DNA sequencing data.
Zhenjiang Zech Xu, PhD
Utilizing machine learning techniques for predictive modeling and biomarker identification for metatranscriptome and metagenome sequencing data.
Pioneering genomics in new markets as founder/CEO. Formerly a VC at XSeed Capital and senior manager at Genentech.
Alexander Aksenov, PhD
Researching bioanalytical chemistry with a focus on biomarker discovery and chemical aspects of biological processes.
Nicola Segata, PhD
Employing experimental meta'omic tools and novel computational approaches to study the diversity of the microbiome across conditions and populations.
Clarity Genomics is honored to collaborate with world-leading experts in microbiome analysis.
Our clients include pharmaceutical (incl. top 5 company), consumer products and biotech companies developing microbiome-based therapeutics.